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Sudden death among athletes is very rare (1:50 000-1:100 000 annually) but it is still 2-4 
times more frequent than in the age-matched control population and attracts significant media 
attention. We propose a mechanism underlying sudden cardiac death in athletes that does not 
relate to myocardial ischaemia but is based on repolarization abnormalities due to potassium 
channel down-regulation and can also be best explained by the concurrent presence of several 
factors such as cardiac hypertrophy (athlete’s heart), and/or hypertrophic cardiomyopathy, 
increased sympathetic tone, genetic defects, drugs, doping agents, food or dietary ingredients. 
These factors together can increase the repolarization inhomogeneity of the heart (“substrate”) 
and an otherwise harmless extrasystole (“trigger”) occurring with a very unfortunate timing 
may sometimes induce life threatening arrhythmias. The effective and possible prevention of 
sudden cardiac death requires the development of novel cost effective cardiac 
electrophysiological screening methods. Athletes identified by these tests as individuals at 
higher proarrhythmic risk should then be subjected to more costly genetic tests in order to 
uncover possible underlying genetic causes for alterations in ionic channel structure and/or 
function. 
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Although there is no doubt that physical exercise and competitive sport are healthy, 
improving quality of life and life expectancy, a number of tragic sudden deaths involving 
young competitive athletes were reported in the press in recent years. 
Fortunately, sudden death among athletes is rare, approximately 1:50 000 – 1:100 000  
[30, 37], however, it is likely that the real prevalence is underestimated by these statistics. 
Even when different statistics are considered, sudden cardiac death (SCD) has been shown to 
be 2 to 4 times more frequent in young athletes compared to their age-matched population 
with no sports activities [14]. In only the minority of cases the cause of SCD is satisfactorily 
established (e.g. trauma, aneurism rupture, acute asthmatic attack, shock etc.) and mostly 
SCD is attributed to ventricular fibrillation. In cases where autopsy findings are inconclusive, 
the ischaemic origin of SCD is often suspected without hard evidence. This explanation can 
be questioned for several reasons. It is compelling that SCD in athletes does not usually 
happen at peak performance, when oxygen demand is the highest in the myocardium, but 
during warmup, after training or during a relatively inactive period of a football game and 
signs of cardiac ischaemia on the ECG or proof of myocardial infarction is very rarely 
observed during or following these events. Furthermore, regular training can be considered as 
one of the most effective activities due to its cardiac preconditioning (antiarrhythmic and 
antiischaemic) effect [26, 33] increasing the chance for survival during these episodes. 
Thus, the cause and mechanism of SCD in competitive athletes must be sought elsewhere.  
 
The proposed mechanism of arrhythmias leading to sudden cardiac death in competitive 
athletes 
 
In normal circumstances, conduction in the heart is fast (1-2 m/s) and the duration of the 
action potential in myocardial cells is long (200-300 ms). Thus these cells are unable to 
become stimulated early, since they are in a refractory state, the length of which can be 
characterized by the effective refractory period (ERP). Importantly, in the normal setting the 
difference between the action potential durations and consequently the ERPs of adjacent cells 
is very small, thus repolarization is homogenous. Fast conduction and homogenous 
repolarization (and refractory period) together prevent the circular re-entry of excitation and 
arrhythmia will not develop. 
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On the other hand, when the duration of repolarization and consequently the refractory 
period of the myocardium is prolonged, the differences in the repolarization of adjacent cells 
also become larger, leading to increased spatial repolarization inhomogeneity (Fig. 1). As a 
consequence, an extrasystole generated after a normal sinus beat can propagate in the 
direction of cells with shorter action potential duration but its propagation will be blocked in 
the direction of cells with a longer action potential duration (Fig. 1). Thus this extra stimulus 
can travel back in a complicated path toward the site of its origin and everywhere else where 
excitability is regained and can generate a chaotic tachycardia or even ventricular fibrillation 
(VF). VF does not revert back to sinus rhythm spontaneously in humans and leads to SCD 
without intervention in a few minutes. It is very important to note that two independent 
factors are needed for the arrhythmia described above and illustrated schematically on 
Figure 1 to develop. Inhomogeneity of repolarization following prolongation of 
repolarization is itself not sufficient for arrhythmia development, establishing only the 
possibility of an arrhythmia (“substrate”). In order to induce arrhythmia, an extrasystole 
in the vulnerable period is needed (“trigger”) that can travel the re-entry paths created by 
the inhomogenous repolarization. The timing of this trigger extrasystole is critical, since 
before the vulnerable period its conduction is blocked and after the vulnerable period it does 
not lead to tachycardia or fibrillation, only a harmless single extrasystole. The larger the 
repolarization inhomogeneity, the longer the vulnerability period and more frequent the 
extrasystole, the bigger the chance becomes for serious arrhythmia development. A similar 
mechanism for arrhythmia generation was demonstrated experimentally in dogs (Figs. 2 and 
3) where the increased repolarization inhomogeneity was induced by blocking the rapid 
delayed rectifier potassium current  (IKr) and the trigger was elicited by external stimulation 
[1]. 
 
Cardiac myocardial hypertrophy in athletes: an important risk factor 
 
It has been known for a long time that strong physical exercise in competitive athletes induces 
adaptation of the cardiovascular system including lower resting heart rate (increased vagal 
tone) and increased cardiac mass (hypertrophy) and volume as a consequence of increased 
demand on the cardiovascular system, called „athlete’s heart”. This is a physiological 
compensatory mechanism that reverses in most cases following the termination of sports 
activities [3]. Lower heart rate favors prolonged repolarization and increased inhomogeneity. 
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A number of echocardiography studies have proven that myocardial hypertrophy develops 
following long-term sports activities [3, 32, 38] and that this hypertrophy is more pronounced 
in male than in female athletes and that the degree of hypertrophy varies with different types 
of exercise training. The most significant increase in left ventricular cavity and wall thickness 
(more than 75%) was detected in cyclists, cross-country skiers, rowers, football players and 
water polo players, while weight lifters, fencers and wrestlers exhibited milder changes (less 
than 50% [29]).  
Interestingly, few conclusive animal experimental data is available in the literature 
regarding the effect of exercise training on cardiac hypertrophy, especially on the cellular 
level and in species that are electrophysiologically relevant to human (i.e. not mouse and rat). 
However, it was speculated that in such situations potassium channel down-regulation might 
occur [23]. 
It is important to emphasize that dogs with chronic atrioventricular (AV) block, as a 
reasonable analogue for athlete’s heart, exhibit marked bradycardia, compensated and 
reversible myocardial hypertrophy three weeks following the induction of AV block [17, 49]. 
The increased duration and inhomogeneity of cardiac repolarization were observed in these 
animals. These dogs with chronic AV block were more susceptible to lethal ventricular 
arrhythmias following different challenges than the corresponding controls [51], (Fig. 4). 
These changes have been primarily attributed to the downregulation of the slow component of 
the delayed rectifier potassium current (IKs), and to a lesser extent to the downregulation of 
other repolarizing potassium currents (Fig. 5), [50]. In addition, the inreased incidence of 
drug-induced arrhythmia correlated better with the increase in short-term beat-to-beat 
variability of the QT interval than with changes of the frequency corrected QT interval (QTc) 
[46]. It is also known that in patients with heart failure and in animals with experimental heart 
failure marked cardiac hypertrophy can be detected that is accompanied by prolongation of 
repolarization and increased arrhythmia propensity [24]. Notably, a significant number of 
heart failure patients die due to lethal ventricular arrhythmias and not due to failing cardiac 
pump function at the earlier stages of heart failure [31]. Evidence suggests that the 
downregulation of transmembrane potassium channels, including IKs, might also be 
responsible for the prolongation of repolarization and increased inhomogeneity of 
repolarization in heart failure [24]. Whether IKs downregulation is a feature of the 
hypertrophic human heart and of the athlete’s heart similarly to that shown in animal models, 
needs to be confirmed. In heart failure, the increased expression (mRNA and protein levels) 
of If channels responsible for spontaneous diastolic depolarization, and of the Na+/Ca2+ 
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exchanger (NCX) have been described [12, 39, 43]. These factors can increase the incidence 
of extrasystoles, serving as arrhythmia triggers. However, reliable data regarding changes in 
the expression of ion channels and exchangers are not available in compensated myocardial 
hypertrophy (e.g. in the “athlete’s heart”). The reversible cardiac hypertrophy induced 
repolarization changes are probably mild since body surface ECG measurements did not 
indicate a significant increase in the duration and inhomogeneity of repolarization in 
competitive athletes [22, 47]. 
Therefore, compensatory cardiac hypertrophy caused by intensive training may lead to 
increased spatial and/or temporal inhomogeneity of repolarization and to impaired 
repolarization reserve. These changes in repolarization can create an arrhythmia substrate and 
may increase arrhythmia propensity in athletes, and albeit rarely, can contribute to sudden 
cardiac death when accompanied by other factors (see below). 
Theoretically, the very high systolic blood pressure observed during strength exercise can 
also contribute to cardiac remodeling and consequently, to increased propensity for sudden 
cardiac death in top athletes.  
 
Increased sympathetic tone 
  
Sudden cardiac death or syncope in athletes usually does not occur during or immediately 
following peak performance, but during warmup or shortly after training, sometimes in the 
dressing room. At this time point, sympathetic tone is still elevated but oxygen demand does 
not differ from resting levels. These circumstances do not support ischaemic origin of sudden 
cardiac death but highlight the importance of elevated intracellular cAMP concentrations 
caused by increased sympathetic tone. The cellular electrophysiological consequences of 
increased cAMP concentrations are multiple. On the one hand, the pacemaker transmembrane 
current (If) increases leading to higher heart rate and development of trigger extrasystoles 
[19]. On the other hand, increased intracellular cAMP enhances L-type calcium current (ICa), 
resulting in increased Ca2+ entry to the cells [40]. This latter event is an important adaptive 
mechanism for positive inotropy besides the increase of heart rate to ensure increased cardiac 
output. Increased Ca2+ entry must be followed by calcium extrusion during steady state that is 
mostly achieved by the increased function of the Na+/Ca2+ exchanger (NCX) partly during 
diastole. At resting membrane potential, i.e. during diastole the NCX pumps out 1 calcium ion 
in exchange for pumping 3 sodium ions into the cell [9]. This has a depolarizing effect that 
can also contribute to the development of extrasystoles. 
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Increased cAMP also enhances IKs function [48] that normally shortens repolarization and 
counterbalances the repolarization prolonging effect of increased L-type calcium current 
induced by increased cAMP. However, when IKs density is reduced by genetic mutations, or 
by IKs downregulation due to cardiac hypertrophy (athlete’s heart), this counterbalancing 
function can become impaired [21, 42] and may lead to prolongation of repolarization and/or 
refractory period creating an arrhythmia substrate in athletes.  
In summary, increased sympathetic tone in athletes can enhance arrhythmia propensity by 







Hypertrophic cardiomyopathy is the most common cause of sudden cardiac death in young 
competitive athletes according to autopsy findings [5, 30, 37]. The disease is a familial 
malformation [5, 10], and mutations in a number of sarcomeric genes have been identified 
that lead to HCM and the developing cardiomegaly and interstitial fibrosis is more significant 
in these patients than even the most pronounced cardiac hypertrophy in competitive athletes. 
HCM is relatively common (1 in 500 of the general population) and in young adults its 
mortality is 1 to 6%. It is very difficult to distinguish HCM from normal compensatory 
hypertrophy in athletes in its early stage. After a 2-3 month sports activity free period 
suspected cases can be identified by echocardiographic studies, since this hypertrophy is not 
reversible. In athletes with HCM the effects of compensatory hypertrophy (athlete’s heart) 
and pathological hypertrophy can add up and result in a dangerous increase of repolarization 
inhomogeneity forming a significant arrhythmia substrate. In addition to HCM, other 
pathological anomalies have been associated with sudden cardiac death in athletes [6, 30, 37], 
including congenital coronary artery anomalies, myocarditis, Wolff-Parkinson-White and 
Brugada syndromes, commotio cordis, sarcoidosis, aortic stenosis and arrhythmogenic right 
ventricular cardiomyopathy [7, 44]. Interestingly, ARVC is regarded as the most common 
known cause for sudden cardiac death in competitive athletes in Italy, possibly due to the 
long-standing 30-year systematic athletic assessment program in that country that identified 
and prevented athletes with HCM from further participation in competitive sports [15, 35]. 
 




Fortunately, the prevalence of genetic defects leading to serious or subclinical repolarization 
disturbances is relatively low. The various types of congenital long QT syndromes have an 
estimated prevalence of 1:5000 in the general population. Studies on competitive athletes 
indicated similar prevalence [4, 25]. Approximately 10% of patients with long QT syndrome 
die due to sudden cardiac death.  The significance of congenital QT syndrome in athletes is 
augmented since the repolarization disturbance occurs in individuals who have a somewhat 
impaired repolarization reserve on the basis of cardiac hypertrophy. Therefore, mutations that 
would otherwise cause only mild abnormalities of repolarization can lead to serious 
arrhythmias in these athletes. This scenario is very likely when mutations occur in genes 
encoding proteins forming the alpha (KvLQT1) and/or beta (minK) subunits for IKs. In this 
case the reduced IKs current (adding to the reduction in IKs caused by cardiac hypertrophy) 
would not be able to compensate for prolonged repolarization caused by increased ICa,L 
current following an elevation in the sympathetic tone. 
Another condition that can pose a threat to athletes that is even higher than in the general 
population is catecholaminergic polymorphic ventricular tachycardia (CPVT), [7]. CPVT 
is a serious abnormality that is related to mutations in genes either encoding proteins of the 
sarcoplasmic reticulum calcium releasing channels (RYR-gene) or calcium binding proteins 
(CASQ2).  The increased sympathetic tone (during sports activities and training) results in 
calcium release from the SR to the cytoplasm in CPVT even during diastole. These events can 
initiate trigger extrasystoles that can initiate serious arrhythmias via the mechanism detailed 
earlier. In athletes with cardiac hypertrophy, where repolarization reserve can be impaired, the 
compensation of the process favouring depolarization in CPVT is reduced and consequently 
extrasystoles can form more easily. 
 
Seemingly harmless medications 
 
It is known that a number of drugs can block the fast component of the delayed rectifier 
potassium (IKr) current, conducted by hERG channels, that leads to repolarization 
prolongation and can sometimes result in proarrhythmic side effects and very rarely in sudden 
cardiac death.  Several frequently used non-cardiac drugs, including H1 antihistamines and 
antibiotics, have been shown to possess such side effects [2, 8]. These compounds are not 
listed as doping agents and therefore can be administered to athletes. However, competitive 
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athletes who have impaired repolarization reserve as a consequence of cardiac hypertrophy, 
the possible proarrhythmic side effects of these drugs can be augmented.  
It is essential to emphasize that a number of compounds frequently used by athletes 
entered the market when drug safety studies, including those looking at QT prolonging 
effects, were less rigorous. Therefore it cannot be ruled out that some of these compounds in 
conjunction with other factors can contribute to the development of lethal ventricular 
arrhythmias in athletes with impaired repolarization reserve. For example, our preliminary 
data indicates that diclofenac moderately inhibits IKr in isolated dog ventricular myocytes. In 
this context, the careful investigation and characterization of the effects of non-steroid 
antiinflammatory drugs (NSAIDs) on ventricular repolarization seems justified, even if these 
effects are found to be marginal. Athletes use NSAIDs very often and in large doses to treat 
different sports injuries while relatively little is known about the cardiac electrophysiologic 
effects of these compounds. Recently, celecoxib has been shown to inhibit rat Kv2.1 
channels, indicating that NSAIDs can indeed block certain potassium channels [20], however, 
inhibition of IKr still remains one of the most important proarrhythmic adverse effects of  




Hypokalaemia can develop during intense sports activities in case fluid replenishment is not 
adequate. The repolarization disturbance augmenting effect of hypokalaemia is well 
characterized and can also contribute to pathologically altered repolarization in athletes with 
cardiac hypertrophy. Reduction in extracellular potassium concentration leads to a substantial 
action potential prolongation that is partly due to decreased IKr and IK1 in the late 




Doping is primarily a problem associated with high level competitive sports and with body 
building activities [18]. Since the application of doping agents is illegal there is few reliable 
data available in the literature on this subject. However, it is known that steroids used for 
doping purposes can lead to skeletal and cardiac muscle hypertrophy [34, 36]. A similar effect 
can be attributed to the application of growth hormone. Therefore, the chronic administration 
of certain doping agents can contribute to the prolongation of repolarization and can increase 
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inhomogeneity of repolarization, creating a substrate for serious ventricular arrhythmia 
generation. Amphetamine-type doping compounds can promote arrhythmia generation via 
another mechanism. These drugs can increase intracellular cAMP levels and, similarly to 
increased sympathetic tone, can promote the development of trigger extrasystoles that may 





Athletes, especially competitive athletes frequently apply special diets, dietary supplements 
and vitamins, however, little is known about their cardiac electrophysiological effects. 
Importantly, according to animal experimental evidence, soy products can increase cardiac 
hypertrophy and worsen heart failure [41]. These effects were more robust in male than in 
female animals [16, 52]. Notably, sudden cardiac death in athletes due to cardiac hypertrophy 
is more frequent in men. Interesting data in connection with grapefruit consumption have also 
been published. According to these results, significant prolongation of the QT interval was 
detected after the ingestion of 1 liter freshly squeezed grapefruit juice and this repolarization 
prolonging effect was attributed to the potassium channel blocking (IKr) effect of certain 
flavonoids present in grapefruit in large quantities [53]. It is also known that grapefruit juice 
interferes with the metabolism of numerous drugs and compounds by inhibiting the 3A4 
isoenzyme of the cytochrome P450 system, leading to potentially unexpected effects when 
grapefruit juice consumption is parallel with administration of certain drugs and other 
chemical compounds including different dietary constituents. It should be emphasized that we 
know so little about the electrophysiological effects of food additives, preservatives, 





As illustrated on Figure 1, two main underlying factors are needed for the development of an 
arrhythmia. On the one hand, a certain degree of inhomogeneity of ventricular repolarization 
is needed that is closely connected to the length of the vulnerability period. A larger 
ventricular repolarization inhomogeneity results in a longer vulnerability period (substrate). 
On the other hand, the more frequently extrasystoles occur, the more likely they will develop 
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during the vulnerability period inducing chaotic ventricular tachycardia or ventricular 
fibrillation. On the level of the individual, however, as a contributor factor, misfortune should 
be emphasized as the most important factor, since in case the trigger extrasystole occurs even 
a fraction of a millisecond prior to or later than the vulnerability period, serious cardiac 
arrhythmia will not develop. In other words, even if all the objective prerequisites for 
arrhythmia development exist (substrate + trigger), the exact but random timing of the trigger 
extrasystoles will determine the induction of a lethal arrhythmic attack in a given individual. 
In the statistical sense, however, in competitive athletes compared to the average population, 
in connection with the increased repolarization inhomogeneity due to cardiac hypertrophy, the 
vulnerability period is probably significantly longer and the sympathetic tone and 
consequently ectopic activity is more often increased for longer periods as a result of regular 
training and competitive game situations. Thus the risk for sudden cardiac death based on 
repolarization abnormalities in competitive athletes should be higher than in the healthy 
average population (first two columns of Fig. 6). The subsidiary risk factors (listed in the third 
column of Fig. 6) contribute to the increased risk associated with competitive sport in an 
additive manner, resulting in an increased chance for serious arrhythmia development in 
athletes.  
 
Prevention of sudden cardiac death in athletes 
 
To avoid any misconception it should be declared again that sports activities monitored by 
expert sports doctors improve life expectancy and quality of life due to their beneficial effects 
on metabolism and on the cardiovascular, immune and respiratory systems. When the 
prevalence of sudden cardiac death is investigated in the whole population, it is found that in 
the majority of cases the cause has an ischaemic origin due to coronary artery disease and in 
only approximately 5% of sudden cardiac death cases cannot be explained clearly and have no 
structural heart disease in the background [11, 45]. Regular sports activities are very useful in 
the prevention of ischaemic heart disease and only represent a very low increase in risk for a 
small group of sudden cardiac deaths.  However, the nature and mechanism of this small 
increase has to be understood and recognized in order to appropriately address this problem 
and to look for sensible solutions. 
One of the main obstacles of sudden cardiac death prevention is its fortunately very low 
incidence (1:50 000 – 1:100 000 annually) making it hard to properly apply statistics, to draw 
general conclusions and to understand the mechanisms. A number of legal debates indicate 
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that the banning of a top competitive athlete from sports is not without problems and cannot 
be carried out based solely on suspected causes [28]. Detailed official statements on 
cardiovascular problems in sports were published in documents of the conference of the 
American College of Cardiology in Bethesda and of the congress of the European Society of 
Cardiology, both in 2005 [15, 27]. The incidence of sudden cardiac death in Italy has been 
significantly reduced in the past 25 years with the application of a relatively low cost (70 
euros per athlete) and thorough cardiovascular screening program [13]. It would be possible 
to successfully screen for the majority of HCM, long QT and AVRS cases using 
echocardiographical and ECG measurements that are more thorough than the currently used 
methods. More careful consideration before the prescription of drugs and application of 
dietary supplements that might prolong repolarization could also bring further results. Novel 
diagnostic tools, such as the calculation of the short-term beat-to-beat temporal variability of 
the QT interval or the application of moderate provocation tests under intensive care 
monitoring could also be considered. In case the suspicion of risk amplification is well 




Unless autopsy findings establish the exact cause of sudden cardiac death in an athlete beyond 
any doubt, the reasons should be sought in repolarization abnormalities rather than in an 
unconfirmed ischaemic origin. Accordingly, more attention should be paid to non-invasive 
cardiac electrophysiological investigations during preventive sports medicine activities and to 
the theoretical and practical cardiac electrophysiological postgraduate training of sports 
doctors. Importantly, unexpected and unexplained syncopes in the anamnesis of athletes 
should be taken seriously and thoroughly investigated. 
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Figure 1. Schematic, simplified illustration of the mechanism of arrhythmia development due 
to increased repolarization dispersion (“arrhythmia substrate”, i.e. the prerequisite for 
arrhythmia development), represented by action potentials with different durations on figure. 
In normal circumstances, sinus impulses (black arrows) propagate through the atrial and 
ventricular tissue and conduction system via physiological pathways. An early ectopic 
impulse (“trigger”, i.e. the actual specific factor that initiates the arrhythmia; red arrows) or a 
preceding extrasystole can only propagate via pathways where cells are not refractory and 
their action potentials are in their vulnerable periods (1, 3, 4, 6), whereas it is blocked in 
directions where the action potentials of cells are in the refractory period (2 and 5). The 
abnormal impulse can travel re-entry paths created by inhomogenous repolarization (7). See 
text for further details. ES: extrasystole; ERP: effective refractory period. 




Figure 2. Experimental demonstration of spatial differences in length of repolarization. Upper 
panel illustrates increased transmural heterogeneity of action potential durations using color 
codes (very long action potentials in red) in bradycardia and d-sotalol administration to mimic 
decreased repolarization reserve in the canine wedge LQT2 model. On lower panel optical 
action potentials are shown from selected transmural sites. Letters (A to D) on lower panel 
refer to areas on upper panel where representative optical action potentials were recorded 
from. Note the significant differences in the action potential duration (indicated by arrows) 
within relatively short distances and within the same transmural layer. Adapted from Akar et 
al., Circulation 2002, 105: 1247-53, with permission. 




Figure 3. Experimental demonstration of the development of Torsades de Pointes arrhythmia 
induced by a premature extra stimulus (S2) in the canine wedge model during bradycardia and 
selective IKr block by d-sotalol. First panel (R) shows repolarization map during S1-S1 
pacing. Panels A to F show depolarization maps with isochrones with reference to the time of 
the S2 impulse. The S2 stimulus was applied on the epicardial surface (top left corner of panel 
A). Spatial differences in action potential duration created a region with delayed 
repolarization (middle region on R panel and c,d, m1-m2 regions on panel A) around which 
the premature stimulus could propagate only in the orthodromic (counterclockwise) direction 
(a’ to e’) but not in the antidromic direction (a to e, conduction blocked in c,d and m1, m2 
regions). Former sites of block (c, d on panel A) regained excitability and the impulse 
propagated back from site e to a (panel B), completing a re-entry circle. Initial broad areas of 
functional conduction block were replaced by functional lines of block during subsequent 
beats of the re-entry arrhythmia (panels C to F). Adapted from Akar et al., Circulation 2002, 
105: 1247-53, with permission. 
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Figure 4.  Chronic AV-block leads to cardiac hypertrophy in dogs. Challenging the heart with 
the selective IKr blocker d-sotalol provoked Torsades de Pointes arrhythmias only in dogs with 
chronic AV-block and impaired repolarization reserve. Adapted from Vos et al., Circulation 
1998, 98: 1125-35, with permission. 
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Figure 5. Experimental evidence for downregulation of IK1, IKs and IKr in hypertrophic dog 
hearts with chronic AV-block, leading to reduced repolarization reserve. Adapted from 
Volders et al., Circulation 1999, 100: 2455-2461, with permission. 




Figure 6. Summary of risk factors most likely involved in sudden cardiac death of 
competitive athletes. HCM: hypertrophic cardiomyopathy; ARVC: arrhythmogenic right 
ventricular cardiomyopathy; CPVT: catecholaminergic polymorphic ventricular tachycardia. 
